Advertisement

Pharmacy World & Science

, Volume 32, Issue 3, pp 350–352 | Cite as

Highly effective treatment with tacrolimus ointment in an adolescent with oral graft-versus-host disease

  • T. BautersEmail author
  • V. Bordon
  • V. Van de Velde
  • S. Van Lancker
  • H. Robays
  • Y. Benoit
  • G. Laureys
Case Report
  • 126 Downloads

Abstract

Case We report a case of acute oral graft-versus-host disease in an adolescent, which was successfully treated with tacrolimus 0.1% ointment. Conclusion Although tacrolimus ointment is not licensed for the indication of oral GvHD, this case report provides preliminary evidence for a potential effectiveness of using tacrolimus in case of failure when GvHD is resistant.

Keywords

Clinical pharmacy Graft-versus-host disease Local application Tacrolimus 

Notes

Conflicts of interest

The authors have no conflicts of interest.

Funding

None.

References

  1. 1.
    Imanguli MM, Pavletic SZ, Guadagnini JP, Brahim JS, Atkinson JC. Chronic graft versus host disease of oral mucosa: review of available therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(2):175–83.CrossRefPubMedGoogle Scholar
  2. 2.
    Imanguli MM, Alevizos I, Brown R, Pavletic SZ, Atkinson JC. Oral graft-versus-host disease. Oral Dis. 2008;14(5):396–412.CrossRefPubMedGoogle Scholar
  3. 3.
    Paczesny Sophie, Choi SungW, Ferrara JamesLM. Acute graft-versus-host disease: new treatment strategies. Curr Opin Hematol. 2009;16(6):427–36.CrossRefPubMedGoogle Scholar
  4. 4.
    E-compendium. Scientific leaflet Protopic [In Flemish]. [cited 2009 August 3]. Available from: http://www.ecompendium.be/.
  5. 5.
    Albert MH, Becker B, Schuster FR, Klein B, Binder V, Adam K, et al. Oral graft vs. host disease in children–treatment with topical tacrolimus ointment. Pediatr Transplant. 2007;11(3):306–11.CrossRefPubMedGoogle Scholar
  6. 6.
    Eckardt A, Starke O, Stadler M, Reuter C, Hertenstein B. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus. Oral Oncol. 2004;40(8):811–4.CrossRefPubMedGoogle Scholar
  7. 7.
    Fricain JC, Sibaud V, Swetyenga N, Tabrizi R, Campana F, Taïeb A. Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease. Br J Dermatol. 2007;156(3):588–90.CrossRefPubMedGoogle Scholar
  8. 8.
    Prot-Labarthe S, Therrien R, Champagne MA, Duval M, Joubert C. Toxic serum levels of tacrolimus after topical administration in an infant with severe cutaneous graft-versus-host disease. Bone Marrow Transplant. 2007;40(3):295–6.CrossRefPubMedGoogle Scholar
  9. 9.
    UpToDate. Waltham, Inc., Massachussets, USA. [cited 2009 August 3]. Available from http://www.utdol.com/.

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • T. Bauters
    • 1
    Email author
  • V. Bordon
    • 2
  • V. Van de Velde
    • 2
  • S. Van Lancker
    • 2
  • H. Robays
    • 1
  • Y. Benoit
    • 2
  • G. Laureys
    • 2
  1. 1.Department of PharmacyGhent University HospitalGhentBelgium
  2. 2.Department of Pediatric Hemato-Oncology and Bone Marrow TransplantationGhent University HospitalGhentBelgium

Personalised recommendations